Latest Action
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
5/30/2023 • Senate
Summary
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act
This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
(The temporary scheduling order issued by the Drug Enforcement Administration to place fentanyl-related substances into schedule I of the Controlled Substances Act expires on December 31, 2024.)
Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).
Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.
The bill also makes several other changes to registration requirements for conducting research with controlled substances, including
- permitting a single registration for related research sites in certain circumstances,
- waiving the requirement for a new inspection in certain situations, and
- allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
Passed House • 5/25/2023
Topics & Subjects
CBO Cost Estimates (1)
Amendments (3)
This bill has 3 amendments proposed or adopted.
View all amendments on Congress.govRelated Federal Spending
Sponsor & Cosponsors (53)
Party Breakdown
Sponsor
Cosponsors (52)
Bill Journey
Originated in the House
Introduced
January 24, 2023
Committee Review
March 8, 2023
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 17 - 10 .
Floor Debate
May 24, 2023
Passed Chamber
May 25, 2023
Other Chamber
President
Enacted into Law
Text Versions (4)
Committee Reports (1)
Related Bills (8)
H.R. 171
HALT Fentanyl Act
H.R. 568
SAFE Act
S. 600
Stopping Overdoses of Fentanyl Analogues Act
H.R. 1580
CEASE Overdose Act of 2023
H.Res. 429
Providing for consideration of the bill (H.R. 467) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes; providing for consideration of the joint resolution (S.J. Res. 11) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency relating to "Control of Air Pollution From New Motor Vehicles: Heavy-Duty Engine and Vehicle Standards"; and providing for consideration of the joint resolution (H.J. Res. 45) providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "Waivers and Modifications of Federal Student Loans".
H.R. 3629
Federal Initiative to Guarantee Health by Targeting Fentanyl Act
S. 1141
HALT Fentanyl Act
H.R. 6184
HALT Fentanyl Act